MLchartDataset catalogue

FoundationOne CDx test

Term · Oncology and biomedicine · MLC-T-ONC-003333

A laboratory test done on a tumor tissue sample to help match a patient's tumor to a specific drug or therapy. A FoundationOne CDx test looks at many different genes in the tissue sample to help identify whether a patient’s tumor has a specific gene mutation (change) or biomarker that is targeted by a particular drug or therapy. This helps determine whether the drug might be an effective treatment for the patient's tumor. A FoundationOne CDx test is a type of companion diagnostic test. FoundationOne is a registered trademark of Foundation Medicine, Inc. Also called F1CDx test.

Table 1. Record
IdentifierMLC-T-ONC-003333
FieldOncology and biomedicine
SynonymsF1CDx test
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003333",
  "term": "FoundationOne CDx test",
  "field": "Oncology and biomedicine",
  "definition": "A laboratory test done on a tumor tissue sample to help match a patient's tumor to a specific drug or therapy. A FoundationOne CDx test looks at many different genes in the tissue sample to help identify whether a patient’s tumor has a specific gene mutation (change) or biomarker that is targeted by a particular drug or therapy. This helps determine whether the drug might be an effective treatment for the patient's tumor. A FoundationOne CDx test is a type of companion diagnostic test. FoundationOne is a registered trademark of Foundation Medicine, Inc. Also called F1CDx test.",
  "synonyms": [
    "F1CDx test"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/foundationone-cdx-test/"
}

Record 7,594 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.